In the early November announcement of its agreement with the government, Lilly pledged to reduce the self-pay price of ...

In the wake of the memo, several vaccine experts responded that the CBER director's claim about the deaths requires more ...

Following the deal’s Nov. 26 close, Omnicom on Monday outlined the structure of the newly combined company, including leaders ...

In this episode of Health Matters, GCI Health’s Ryan Kuresman and Health@WPP’s Wendy Lund explore the fast-shifting landscape ...

The Trump administration has lined up another country-specific trade agreement, this time with the U.K., which confers Washington’s biggest break on pharmaceutical import tariffs yet. | The Trump ...

Mitsubishi Tanabe Pharma has undergone a rebrand. Following a 510 billion Japanese yen ($3.3 billion) takeover by Bain Capital, the 350-year-old company has dropped Mitsubishi from its name and those ...

Microsize, a U.S.-based CDMO that specializes in particle size reduction and control technologies, has linked with Swiss equipment provider Schedio Group ...

The United States has revealed price reductions for the second round of | The U.S. has revealed price reductions for the ...

Less than a week after Novartis unveiled a plan to establish a “flagship manufacturing hub” in North Carolina that would add ...

With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) ...

AstraZeneca’s Imfinzi is adding yet another landmark perioperative label to its belt with a new FDA approval that gives the ...

Facing the fact that Lundbeck’s unexpected offer for Avadel Pharmaceuticals was sweeter, Alkermes has come back to the ...